- Type / Class
- Equity / Class A Stock
- Shares outstanding
- 115,244,363
- Total 13F shares
- 114,075,801
- Share change
- +4,842,726
- Total reported value
- $6,730,550,265
- Put/Call ratio
- 4.6%
- Price per share
- $59.02
- Number of holders
- 477
- Value change
- +$195,769,879
- Number of buys
- 258
- Number of sells
- 241
Quarterly Holders Quick Answers
What is CUSIP 379577208?
CUSIP 379577208 identifies GMED - GLOBUS MEDICAL INC - Class A Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 379577208:
Top shareholders of GMED - GLOBUS MEDICAL INC - Class A Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
9.5%
|
10,909,082
|
$798,544,802 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
9.1%
from 13D/G
|
10,723,911
|
$784,990,284 | — | 31 Mar 2025 | |
| JANUS HENDERSON GROUP PLC |
13D/G
13F
|
Company |
6.1%
|
7,029,294
|
$522,135,958 | +$30,787,723 | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
3.1%
|
3,615,523
|
$264,656,284 | — | 31 Mar 2025 | |
| Burgundy Asset Management Ltd. |
13F
|
Company |
2.4%
|
2,801,747
|
$205,087,880 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
2.3%
|
2,628,382
|
$192,397,595 | — | 31 Mar 2025 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
2%
|
2,273,787
|
$166,441,208 | — | 31 Mar 2025 | |
| Sculptor Capital LP |
13F
|
Company |
1.8%
|
2,092,838
|
$153,195,742 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.8%
|
2,032,233
|
$148,805,061 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
1.8%
|
2,021,156
|
$147,948,637 | — | 31 Mar 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.6%
|
1,882,415
|
$137,792,777 | — | 31 Mar 2025 | |
| GENEVA CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.6%
|
1,833,647
|
$134,222,964 | — | 31 Mar 2025 | |
| GW&K Investment Management, LLC |
13F
|
Company |
1.5%
|
1,719,928
|
$125,899,000 | — | 31 Mar 2025 | |
| HAWK RIDGE CAPITAL MANAGEMENT LP |
13F
|
Company |
1.5%
|
1,680,075
|
$122,981,490 | — | 31 Mar 2025 | |
| AXA S.A. |
13F
|
Company |
1.2%
|
1,402,205
|
$102,641,406 | — | 31 Mar 2025 | |
| Camber Capital Management LP |
13F
|
Company |
1.1%
|
1,250,000
|
$91,500,000 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1%
|
1,188,130
|
$86,971,116 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1%
|
1,163,834
|
$85,192,544 | — | 31 Mar 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1%
|
1,148,379
|
$84,062,000 | — | 31 Mar 2025 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
0.98%
|
1,125,000
|
$82,350,000 | — | 31 Mar 2025 | |
| Van Berkom & Associates Inc. |
13F
|
Company |
0.97%
|
1,118,432
|
$81,869,000 | — | 31 Mar 2025 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.95%
|
1,098,103
|
$80,381,140 | — | 31 Mar 2025 | |
| Polar Capital Holdings Plc |
13F
|
Company |
0.91%
|
1,050,380
|
$76,887,816 | — | 31 Mar 2025 | |
| Champlain Investment Partners, LLC |
13F
|
Company |
0.9%
|
1,041,208
|
$76,216,426 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.87%
|
1,008,198
|
$73,800,094 | — | 31 Mar 2025 | |
| PARADIGM CAPITAL MANAGEMENT INC/NY |
13F
|
Company |
0.82%
|
949,300
|
$69,488,760 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.81%
|
928,944
|
$67,998,701 | — | 31 Mar 2025 | |
| FULLER & THALER ASSET MANAGEMENT, INC. |
13F
|
Company |
0.8%
|
919,228
|
$67,287,496 | — | 31 Mar 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.76%
|
873,784
|
$63,960,989 | — | 31 Mar 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.72%
|
833,146
|
$60,986,286 | — | 31 Mar 2025 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
0.69%
|
798,783
|
$58,470,916 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.65%
|
746,838
|
$54,668,542 | — | 31 Mar 2025 | |
| Parsifal Capital Management, LP |
13F
|
Company |
0.65%
|
745,822
|
$54,594,170 | — | 31 Mar 2025 | |
| VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. |
13F
|
Company |
0.63%
|
731,192
|
$53,522,000 | — | 31 Mar 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.63%
|
721,764
|
$52,832,146 | — | 31 Mar 2025 | |
| Artemis Investment Management LLP |
13F
|
Company |
0.63%
|
720,593
|
$52,747,408 | — | 31 Mar 2025 | |
| Global Alpha Capital Management Ltd. |
13F
|
Company |
0.61%
|
707,691
|
$51,802,981 | — | 31 Mar 2025 | |
| THRIVENT FINANCIAL FOR LUTHERANS |
13F
|
Company |
0.61%
|
705,047
|
$51,609,000 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.61%
|
698,969
|
$51,164,533 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.59%
|
683,101
|
$50,003,134 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.58%
|
669,352
|
$48,996,567 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.56%
|
649,376
|
$47,523,262 | — | 31 Mar 2025 | |
| Stephens Investment Management Group LLC |
13F
|
Company |
0.56%
|
645,057
|
$47,218,172 | — | 31 Mar 2025 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.54%
|
619,958
|
$45,381,000 | — | 31 Mar 2025 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.53%
|
605,770
|
$44,342,364 | — | 31 Mar 2025 | |
| Grantham, Mayo, Van Otterloo & Co. LLC |
13F
|
Company |
0.51%
|
589,277
|
$43,135,076 | — | 31 Mar 2025 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.5%
|
579,861
|
$42,446,000 | — | 31 Mar 2025 | |
| Capital World Investors |
13F
|
Company |
0.5%
|
574,500
|
$42,053,400 | — | 31 Mar 2025 | |
| ANCHOR CAPITAL ADVISORS LLC |
13F
|
Company |
0.47%
|
536,977
|
$39,306,749 | — | 31 Mar 2025 | |
| Pembroke Management, LTD |
13F
|
Company |
0.46%
|
533,429
|
$39,047,003 | — | 31 Mar 2025 |
Institutional Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q2 2025
As of 30 Jun 2025,
GLOBUS MEDICAL INC - Class A Stock (GMED) was held by
477 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
114,075,801 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, Burgundy Asset Management Ltd., STATE STREET CORP, JPMORGAN CHASE & CO, Sculptor Capital LP, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, HAWK RIDGE CAPITAL MANAGEMENT LP, and GENEVA CAPITAL MANAGEMENT LLC.
This page lists
478
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
507
Q2 2025 holders
477
Holder diff
-30
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.